CompletedNAResults postedLast updated 28 July 2025
What this trial tests
NA trial testing Mesenchymal stem cell augmentation in rotator cuff repair in Full Thickness Rotator Cuff Tear in 62 participants. Completed in 27 June 2024.
Adults 18 to 70, any sex, with Full Thickness Rotator Cuff Tear. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
American Shoulder and Elbow Surgeons (ASES) ScorePrimary· One year
The American Shoulder and Elbow Surgeons (ASES) score is a patient-reported score that measures shoulder pain, activity level and stability.
The score ranges from 0 to 100, with higher scores indicating better shoulder function.
Excellent: 90-100 points Good: 70-89 points Fair: 40-49 points Poor: Less than 39 points
Group
Value
95% CI
Rotator Cuff Repair With Stem Cells
87
0 – 100
Rotator Cuff Repair Without Stem Cells
89
0 – 100
Sponsor's own description
The primary objective of this study is to compare the clinical outcomes of arthroscopic rotator cuff repair with and without augmentation of mesenchymal stem cells (MSCs). Mesenchymal stem cells promote tissue regeneration by differentiating into adult cell lines and by supplying growth factors to their implanted environment. They have been shown to be effective in improving both overall healing and tendon integrity in rotator cuff repair. This study will follow 100 patients in the United States and track their clinical outcomes for at least one year post-operatively.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rush University Medical Center
Last refreshed: 28 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02484950.